MedPath

BeiGene

🇨🇳China
Ownership
-
Established
2018-06-28
Employees
10K
Market Cap
-
Website
http://www.beigene.com
Introduction

The company's mission is to become a global leader in the discovery, development and commercialization of innovative molecular-targeted immuno-oncology drugs to treat cancer. The company focuses on R&D, production and commercialization of innovative drugs. The main products are anti-tumor drugs, etc.

© Copyright 2025. All Rights Reserved by MedPath